CPTAC Lung Squamous Cell Carcinoma and Lung Adenocarcinoma Baseline Form

Preferred Label : CPTAC Lung Squamous Cell Carcinoma and Lung Adenocarcinoma Baseline Form;

NCI Metathesaurus CUI : CL951275;

Details

Origin ID

C159417;

UMLS CUI

C5204415;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- AJCC Cancer Staging Manual 7th Edition [NCIt concept]
- AJCC Cancer Staging Manual 8th Edition [NCIt concept]
- ALK Gene Rearrangement [NCIt concept]
- ALK Gene Rearrangement Negative [NCIt concept]
- ALK Rearrangement Analysis [NCIt concept]
- ALK Rearrangement Analysis Was Not Performed [NCIt concept]
- ALK Rearrangement Analysis Was Performed [NCIt concept]
- ALK Rearrangement Testing Method [NCIt concept]
- Acinar Cell Carcinoma [NCIt concept]
- Ancillary Study [NCIt concept]
- BRAF Gene Mutation Negative [NCIt concept]
- BRAF Mutation Analysis Testing Method [NCIt concept]
- BRAF Mutation Analysis Was Not Performed [NCIt concept]
- BRAF Mutation Analysis Was Performed [NCIt concept]
- BRAF NM_004333.4:c.1799T>A [NCIt concept]
- BRAF NP_004324.2:p.V600X [NCIt concept]
- Basaloid Squamous Cell Carcinoma [NCIt concept]
- CDR Entry Completed by (signature) [NCIt concept]
- CPTAC Case Identifier [NCIt concept]
- Centimeter [NCIt concept]
- Central Lung Parenchyma Tumor [NCIt concept]
- Comment [NCIt concept]
- Confirm AJCC/TNM Cancer Staging Edition [NCIt concept]
- DLCO % REF [NCIt concept]
- Date [NCIt concept]
- ECOG Performance Status 0 [NCIt concept]
- ECOG Performance Status 1 [NCIt concept]
- ECOG Performance Status 2 [NCIt concept]
- ECOG Performance Status 3 [NCIt concept]
- ECOG Performance Status 4 [NCIt concept]
- ECOG Performance Status not Evaluated, not Provided or Available [NCIt concept]
- EGFR Exon 19 Deletion Mutation [NCIt concept]
- EGFR Exon 20 Insertion Mutation [NCIt concept]
- EGFR Gene Mutation [NCIt concept]
- EGFR Gene Mutation Negative [NCIt concept]
- EGFR Mutation Analysis Testing Method [NCIt concept]
- EGFR Mutation Analysis Was Not Performed [NCIt concept]
- EGFR Mutation Analysis Was Performed [NCIt concept]
- EGFR NP_005219.2:p.G719X [NCIt concept]
- EGFR NP_005219.2:p.L858R [NCIt concept]
- EGFR NP_005219.2:p.T790M [NCIt concept]
- ERBB2 Exon 20 Mutation [NCIt concept]
- ERBB2 Gene Mutation Negative [NCIt concept]
- ERBB2 Mutation Analysis [NCIt concept]
- ERBB2 Mutation Analysis Testing Method [NCIt concept]
- ERBB2 Mutation Analysis Was Not Performed [NCIt concept]
- ERBB2 Mutation Analysis Was Performed [NCIt concept]
- ERBB2 NP_004439.2:p.G776delinsVC [NCIt concept]
- ERBB2 NP_004439.2:p.Y772_A775dup [NCIt concept]
- FEV1% REF Post-Bronchodilator [NCIt concept]
- FEV1% REF Pre-Bronchodilator [NCIt concept]
- FEV1/FVC Post-Bronchodilator [NCIt concept]
- FEV1/FVC Pre-Bronchodilator [NCIt concept]
- Form Completed by (Signature) [NCIt concept]
- Grade X [NCIt concept]
- Greatest Dimension Tumor [NCIt concept]
- Histologic Grade [NCIt concept]
- Histologic Type [NCIt concept]
- IHC Staining not Done [NCIt concept]
- If Other Edition, Specify [NCIt concept]
- If Other, Specify [NCIt concept]
- Immunohistochemistry Was Not Performed [NCIt concept]
- Immunohistochemistry Was Performed [NCIt concept]
- Incomplete Staging (cM) [NCIt concept]
- Incomplete Staging (pM) [NCIt concept]
- Initial Cancer Diagnosis Date [NCIt concept]
- Invasive Lung Mucinous Adenocarcinoma [NCIt concept]
- Is Another Non-Exon 20 ERBB2 Mutation Present [NCIt concept]
- Is Paraneoplastic Syndrome Present [NCIt concept]
- Is Tumor Cell Necrosis Present [NCIt concept]
- KRAS Gene Mutation [NCIt concept]
- KRAS Gene Mutation Negative [NCIt concept]
- KRAS Mutation Analysis Testing Method [NCIt concept]
- KRAS Mutation Analysis Was Not Performed [NCIt concept]
- KRAS Mutation Analysis Was Performed [NCIt concept]
- KRAS NM_004985.3:c.182A>T [NCIt concept]
- KRAS NM_004985.3:c.34G>A [NCIt concept]
- KRAS NM_004985.3:c.34G>C [NCIt concept]
- KRAS NM_004985.3:c.34G>T [NCIt concept]
- KRAS NM_004985.3:c.35G>A [NCIt concept]
- KRAS NM_004985.3:c.35G>C [NCIt concept]
- KRAS NM_004985.3:c.35G>T [NCIt concept]
- KRAS NM_004985.3:c.37G>C [NCIt concept]
- KRAS NM_004985.3:c.37G>T [NCIt concept]
- KRAS NM_004985.3:c.38G>A [NCIt concept]
- KRAS NM_004985.3:c.38G>C [NCIt concept]
- KRAS NM_004985.3:c.38G>T [NCIt concept]
- KRAS NP_004976.2:p.G12X [NCIt concept]
- KRAS NP_004976.2:p.G13X [NCIt concept]
- KRAS NP_004976.2:p.Q61X [NCIt concept]
- Karnofsky Performance Status 0 [NCIt concept]
- Karnofsky Performance Status 10 [NCIt concept]
- Karnofsky Performance Status 100 [NCIt concept]
- Karnofsky Performance Status 20 [NCIt concept]
- Karnofsky Performance Status 30 [NCIt concept]
- Karnofsky Performance Status 40 [NCIt concept]
- Karnofsky Performance Status 50 [NCIt concept]
- Karnofsky Performance Status 60 [NCIt concept]
- Karnofsky Performance Status 70 [NCIt concept]
- Karnofsky Performance Status 80 [NCIt concept]
- Karnofsky Performance Status 90 [NCIt concept]
- Karnofsky Performance Status Not Evaluated [NCIt concept]
- Karnofsky Performance Status Unknown [NCIt concept]
- Lepidic Adenocarcinoma [NCIt concept]
- Lower Lobe of the Lung [NCIt concept]
- Lung Adenocarcinoma [NCIt concept]
- Lung Cancer Clinical Distant Metastasis TNM Finding v7 [NCIt concept]
- Lung Cancer Pathologic Distant Metastasis TNM Finding v7 [NCIt concept]
- Lung Cancer Pathologic Primary Tumor TNM Finding v7 [NCIt concept]
- Lung Cancer Pathologic Regional Lymph Nodes TNM Finding v7 [NCIt concept]
- Lung Cancer by AJCC v8 Stage [NCIt concept]
- Lung Cancer cM0 TNM Finding v8 [NCIt concept]
- Lung Cancer cM1 TNM Finding v8 [NCIt concept]
- Lung Cancer cM1a TNM Finding v8 [NCIt concept]
- Lung Cancer cM1b TNM Finding v8 [NCIt concept]
- Lung Cancer pM1 TNM Finding v7 [NCIt concept]
- Lung Cancer pM1a TNM Finding v7 [NCIt concept]
- Lung Cancer pM1b TNM Finding v7 [NCIt concept]
- Lung Cancer pN0 TNM Finding v6 and v7 [NCIt concept]
- Lung Cancer pN1 TNM Finding v7 [NCIt concept]
- Lung Cancer pN2 TNM Finding v6 and v7 [NCIt concept]
- Lung Cancer pN3 TNM Finding v6 and v7 [NCIt concept]
- Lung Cancer pNX TNM Finding v6 and v7 [NCIt concept]
- Lung Cancer pT0 TNM Finding v6 and v7 [NCIt concept]
- Lung Cancer pT1 TNM Finding v7 [NCIt concept]
- Lung Cancer pT1a TNM Finding v7 [NCIt concept]
- Lung Cancer pT1b TNM Finding v7 [NCIt concept]
- Lung Cancer pT2 TNM Finding v7 [NCIt concept]
- Lung Cancer pT2a TNM Finding v7 [NCIt concept]
- Lung Cancer pT2b TNM Finding v7 [NCIt concept]
- Lung Cancer pT3 TNM Finding v7 [NCIt concept]
- Lung Cancer pT4 TNM Finding v7 [NCIt concept]
- Lung Cancer pTX TNM Finding v6 and v7 [NCIt concept]
- Lung Enteric Adenocarcinoma [NCIt concept]
- Lung Fetal Adenocarcinoma [NCIt concept]
- Lung Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Lung Micropapillary Adenocarcinoma [NCIt concept]
- Lung Non-Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Lung Parenchyma Tumor Location [NCIt concept]
- MET Codon 1010 Splice Mutation [NCIt concept]
- MET Codon 963 Splice Mutation [NCIt concept]
- MET Exon 14 Skipping Mutation [NCIt concept]
- MET Gene Mutation [NCIt concept]
- MET Gene Mutation Negative [NCIt concept]
- MET Mutation Analysis Testing Method [NCIt concept]
- MET Mutation Analysis Was Not Performed [NCIt concept]
- MET Mutation Analysis Was Performed [NCIt concept]
- MET NP_000236.2:p.D1010N [NCIt concept]
- Main Bronchus [NCIt concept]
- Margin Involved by Invasive Carcinoma [NCIt concept]
- Margin Status Cannot be Assessed [NCIt concept]
- Margin Uninvolved by Invasive Carcinoma [NCIt concept]
- Middle Lobe of the Right Lung [NCIt concept]
- Moderately Differentiated [NCIt concept]
- Month-Day-Year [NCIt concept]
- Mucinous Adenocarcinoma [NCIt concept]
- Multifocal Lesion [NCIt concept]
- Mutation Analysis Was Not Performed [NCIt concept]
- Mutation Analysis Was Performed [NCIt concept]
- No Evidence of Tumor Cell Necrosis Present [NCIt concept]
- No Pathologic Evidence of Distant Metastasis [NCIt concept]
- Not Known if ALK Rearrangement Analysis Was Performed [NCIt concept]
- Not Known if BRAF Mutation Analysis Was Performed [NCIt concept]
- Not Known if EGFR Mutation Analysis Was Performed [NCIt concept]
- Not Known if ERBB2 Mutation Analysis Was Performed [NCIt concept]
- Not Known if Immunohistochemistry Was Performed [NCIt concept]
- Not Known if KRAS Mutation Analysis Was Performed [NCIt concept]
- Not Known if MET Mutation Analysis Was Performed [NCIt concept]
- Not Known if Mutation Analysis Was Performed [NCIt concept]
- Not Known if RET Rearrangement Analysis Was Performed [NCIt concept]
- Not Known if ROS1 Rearrangement Analysis Was Performed [NCIt concept]
- Number of Lymph Nodes Examined [NCIt concept]
- Number of Lymph Nodes Positive for Tumor by H&E [NCIt concept]
- Number of Lymph Nodes Positive for Tumor by IHC Staining Only [NCIt concept]
- Organ of Origin [NCIt concept]
- Other Edition [NCIt concept]
- Other Histologic Type [NCIt concept]
- Other Tumor Site [NCIt concept]
- Papillary Adenocarcinoma [NCIt concept]
- Paraneoplastic Syndrome Status is Unknown [NCIt concept]
- Paraneoplastic Syndrome is Not Present [NCIt concept]
- Paraneoplastic Syndrome is Present [NCIt concept]
- Performance Status [NCIt concept]
- Peripheral Lung Parenchyma Tumor [NCIt concept]
- Poorly Differentiated [NCIt concept]
- Preoperative ECOG - Performance Status [NCIt concept]
- Preoperative Karnofsky Performance Status [NCIt concept]
- Print, Sign, Date Form [NCIt concept]
- Pulmonary Function Test [NCIt concept]
- RET Gene Rearrangement Negative [NCIt concept]
- RET Rearrangement Analysis [NCIt concept]
- RET Rearrangement Analysis Was Not Performed [NCIt concept]
- RET Rearrangement Analysis Was Performed [NCIt concept]
- RET Rearrangement Testing Method [NCIt concept]
- RET/PTC Rearrangement [NCIt concept]
- ROS1 Gene Rearrangement [NCIt concept]
- ROS1 Gene Rearrangement Negative [NCIt concept]
- ROS1 Rearrangement Analysis [NCIt concept]
- ROS1 Rearrangement Analysis Was Not Performed [NCIt concept]
- ROS1 Rearrangement Analysis Was Performed [NCIt concept]
- ROS1 Rearrangement Testing Method [NCIt concept]
- Residual Disease [NCIt concept]
- Select All That Apply [NCIt concept]
- Select Histologic Type [NCIt concept]
- Select One [NCIt concept]
- Site of Tumor [NCIt concept]
- Solid Lung Adenocarcinoma [NCIt concept]
- Specify [NCIt concept]
- Specify Mutation Analysis Method [NCIt concept]
- Specify Number of Lymph Nodes Examined [NCIt concept]
- Specify Number of Lymph Nodes Positive for Tumor by H&E [NCIt concept]
- Specify Number of Lymph Nodes Positive for Tumor by IHC Staining Only [NCIt concept]
- Specify Other BRAF Codon 600 Mutation [NCIt concept]
- Specify Other ERBB2 Non-Exon 20 Mutation [NCIt concept]
- Specify Other KRAS Codon 12 Mutation [NCIt concept]
- Specify Other KRAS Codon 13 Mutation [NCIt concept]
- Specify Other KRAS Codon 61 Mutation [NCIt concept]
- Specify Other KRAS Codon Mutation [NCIt concept]
- Specify Other MET Exon 14 Mutation [NCIt concept]
- Specify Other MET Intron 13 Mutation [NCIt concept]
- Specify Other MET Intron 14 Mutation [NCIt concept]
- Specify Other MET Mutation [NCIt concept]
- Specify Other Tumor Site [NCIt concept]
- Specify Site if Documented Distant Metastasis [NCIt concept]
- Specify Type of Testing and Results if Yes [NCIt concept]
- Squamous Cell Carcinoma [NCIt concept]
- Stage I Lung Cancer AJCC v8 [NCIt concept]
- Stage IB Lung Cancer AJCC v8 [NCIt concept]
- Stage II Lung Cancer AJCC v8 [NCIt concept]
- Stage IIA Lung Cancer AJCC v8 [NCIt concept]
- Stage IIB Lung Cancer AJCC v8 [NCIt concept]
- Stage III Lung Cancer AJCC v8 [NCIt concept]
- Stage IIIA Lung Cancer AJCC v8 [NCIt concept]
- Stage IIIB Lung Cancer AJCC v8 [NCIt concept]
- Stage IV Lung Cancer AJCC v8 [NCIt concept]
- Stage R0 [NCIt concept]
- Stage R1 [NCIt concept]
- Stage R2 [NCIt concept]
- Stage RX [NCIt concept]
- Surgical Margins Status [NCIt concept]
- Tissue Source Site [NCIt concept]
- Tissue Source Site Identifier [NCIt concept]
- Transcribe Data into CDR and Record the Following [NCIt concept]
- Tumor Cell Necrosis is Present [NCIt concept]
- Tumor Findings Laterality [NCIt concept]
- Tumor Focality [NCIt concept]
- Tumor Laterality Left [NCIt concept]
- Tumor Laterality Right [NCIt concept]
- Tumor Location Unknown [NCIt concept]
- Undifferentiated [NCIt concept]
- Unifocal Lesion [NCIt concept]
- Unknown ECOG Performance Status [NCIt concept]
- Upper Lobe of the Lung [NCIt concept]
- Was ALK Rearrangement Analysis Performed [NCIt concept]
- Was Additional Mutation Analysis Performed [NCIt concept]
- Was Additional Testing Performed [NCIt concept]
- Was BRAF Mutation Analysis Performed [NCIt concept]
- Was EGFR Mutation Analysis Performed [NCIt concept]
- Was ERBB2 Mutation Analysis Performed [NCIt concept]
- Was Immunohistochemical Testing Performed [NCIt concept]
- Was KRAS Mutation Analysis Performed [NCIt concept]
- Was MET Mutation Analysis Performed [NCIt concept]
- Was RET Rearrangement Analysis Performed [NCIt concept]
- Was ROS1 Rearrangement Analysis Performed [NCIt concept]
- Well Differentiated [NCIt concept]
- Which Pulmonary Function Tests Were Performed [NCIt concept]
- Wild Type [NCIt concept]
- Yes [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients